India's Supreme Court ruling in Novartis v. Union of India adopting a strict interpretation of the country's new patent law represents a step toward a “patent law 2.0” that may help ensure access to medicines and align drug innovation with public health needs.
No takes yet. Share an insight, caveat, or question.
Amy Kapczynski (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: